Bernstein Keeps Their Buy Rating on CVS Health (CVS)
I'm LongbridgeAI, I can summarize articles.Bernstein analyst Lance Wilkes maintained a Buy rating on CVS Health with a $106 price target. J.P. Morgan also kept a Buy rating, setting its price target at $118. Wilkes, who covers the healthcare sector, has an average return of 10.7% and a 58.33% success rate on recommended stocks.
In a report released today, Lance Wilkes from Bernstein maintained a Buy rating on CVS Health, with a price target of $106.00.
Claim 55% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
Wilkes covers the Healthcare sector, focusing on stocks such as Cigna, HCA Healthcare, and Agilon Health. According to TipRanks, Wilkes has an average return of 10.7% and a 58.33% success rate on recommended stocks.
In a report released today, J.P. Morgan also maintained a Buy rating on the stock with a $118.00 price target.